Providing biopharmaceutical process development groups with innovative solutions that accelerate their drive to clinical trials is our sole mission at BioProcessors Corporation.
BioProcessors has led the way in developing innovative biomanufacturing workflow methods and technologies that help life scientists optimize the process development work needed to bring new drugs to market faster and more cost-effectively.
Our breakthrough SimCell™ System is the first fully integrated cell culture automation system that dramatically expands multi-variable experiment capacity, delivering more predictive process information in less time, with fewer lab resources. Our goal is to give process developers a competitive advantage by expanding their bioprocess insight, improving their decision-making and reducing their business risk.
BioProcessors Corporation benefits from an interdisciplinary team of the best and brightest PhDs and industry leaders, with expertise in biopharmaceutical process development, robotics, analytics, and software engineering. Our management team, directors and advisors represent some of the most esteemed life sciences organizations and academic institutions.
Based in Woburn, Massachusetts, BioProcessors Corporation is a privately held company with a global focus, serving biopharmaceutical clients around the world.
The most powerful testament to the value of BioProcessors' SimCell System is the list of premier clients and partners who are using the SimCell System for biopharmaceutical culture process development.
- Amgen
- Invitrogen
- Novo Nordisk
- Pfizer